Latest Stock Buy or Sell? Make More Informed Decisions!

In their watch list but it is going to take a while to restructure the company. Still to early. Would wait until the CEO has an investor call.

Canadian Banks didn't do well in 2018. But the multiple contracted dramatically trading below 10x earnings now. Valuation is very attractive. Yield of 3.9%. Good growth in the US. They are still 70% retail. Capital markets (that tends to be more volatile) is only 8% of their revenues. They are deposit based. They can grow their earnings by 6-7% this year. Banks have a target payout ratio of 40 to 50% of earnings. (Analysts’ price target is $83.93)

They owned for a number of years. 35% of their business is in the US and 40% emerging markets. Well diversified. They have four divisions: nutritionals, established pharmaceuticals, generics and medical devices and diagnostics. She sees double digit growth in earnings. (Analysts’ price target is $78.57)

Leading global payment platform. As more and more people buy online they benefit. Under penetrated in Europe. They bought Visa Europe a couple of years ago that was run before as a not for profit. Good secular growth in the space. She thinks that they can grow their earnings at a 15% - 20% rate. Valuation very attractive. (Analysts’ price target is $161.35)